Skip to content

Kezar Life Sciences, Inc.

CIK 0001645666

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$47.24M
+33.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$6.45
+33.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$68.66M
Q1 May 2026
Cash
$66.23M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
7.39M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings